Illumina and Nashville Biosciences Announce Sequencing Agreement With Amgen
Originally published on Illumina News CenterSAN DIEGO, CA / ACCESSWIRE / January 9, 2023 / Illumina Inc. (NASDAQ:ILMN), a global leader in DNA sequencing and array-based technologies, and Nashville Biosciences